(Q40775594)

23 September 2017

title

N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction (English)

1 reference

23 September 2017

1 reference

Assil IQ

1

1 reference

23 September 2017

Abou-Samra AB

series ordinal

2

1 reference

23 September 2017

publication date

1 November 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

23 September 2017

published in

1 reference

23 September 2017

volume

281

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

E1015-21

1 reference

Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Expression cloning of a human corticotropin-releasing-factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Cloning and characterization of human urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

N-linked glycosylation of the human Ca2+ receptor is essential for its expression at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Rapid and efficient site-specific mutagenesis without phenotypic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Urocortin, a novel neuropeptide with anxiogenic-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

N-glycosylation contributes to the intracellular stability of prothrombin precursors in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

The structures of the mouse and human urocortin genes (Ucn and UCN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Role of asparagine-linked oligosaccharides in the function of the rat PTH/PTHrP receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1015

10.1152/AJPENDO.2001.281.5.E1015

21 January 2018

Identifiers

DOI

0 references

1 reference